FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1964602635> ?p ?o ?g. }

• W1964602635 endingPage "657" @default.
• W1964602635 startingPage "647" @default.
• W1964602635 abstract "Cancer gene therapy for the treatment of lung cancer has shown promise in the laboratory and in Phase I/II clinical trials. However, it is currently limited to treating localized tumors due to host-immunity against the gene delivery vector and the transgene. Therefore, there is a tremendous effort to develop and test alternate gene delivery vectors that are efficient, non-immunogenic, and applicable for systemic therapy. One such gene delivery vehicle is the non-viral vector, DOTAP: cholesterol (DOTAP:Chol) nanoparticle. Preclinical studies from our laboratory has shown that DOTAP:Chol. nanoparticles are effective systemic gene delivery vectors that efficiently deliver tumor-suppressor genes to disseminated lung tumors. Based on our findings we have recently initiated a Phase-I trial for systemic treatment of lung cancer using a novel tumor suppressor gene, FUS1. Although DOTAP:Chol. nanoparticles complexed to DNA (DNA-nanoparticles) are efficient vectors for systemic therapy, induction of an inflammatory response in a dose-dependent fashion has also been observed thereby limiting its use. A better understanding of the underlying mechanism for DNA-nanoparticles-mediated inflammatory response will allow us to develop strategies to suppress inflammation and expand the therapeutic window in treating human cancer. In the present study we conducted experiments examining the mechanism of nanoparticle-mediated inflammatory response in vitro and in vivo. We demonstrate that systemic administration of DNA-nanoparticles induced multiple signaling molecules both in vitro and in vivo that are associated with inflammation. Use of small molecule inhibitors against the signaling molecules resulted in their suppression and thereby reduced inflammation without affecting transgene expression. Our results provide a rationale to use small molecule inhibitors to suppress nanoparticle-mediated inflammation when administered systemically. Further development and testing will allow us to incorporate this strategy into future clinical trials that is based on systemic non-viral vector gene therapy." @default.
• W1964602635 created "2016-06-24" @default.
• W1964602635 creator A5027152610 @default.
• W1964602635 creator A5031087657 @default.
• W1964602635 creator A5055713619 @default.
• W1964602635 creator A5066691984 @default.
• W1964602635 creator A5068736204 @default.
• W1964602635 creator A5078088995 @default.
• W1964602635 date "2004-12-01" @default.
• W1964602635 modified "2023-10-01" @default.
• W1964602635 title "Nanoparticle Based Systemic Gene Therapy for Lung Cancer: Molecular Mechanisms and Strategies to Suppress Nanoparticle-Mediated Inflammatory Response" @default.
• W1964602635 cites W1501675811 @default.
• W1964602635 cites W1599588446 @default.
• W1964602635 cites W1950719160 @default.
• W1964602635 cites W1965769436 @default.
• W1964602635 cites W1972089696 @default.
• W1964602635 cites W1976498232 @default.
• W1964602635 cites W1977303977 @default.
• W1964602635 cites W1990406980 @default.
• W1964602635 cites W1991190678 @default.
• W1964602635 cites W1996081359 @default.
• W1964602635 cites W1997954003 @default.
• W1964602635 cites W1999461960 @default.
• W1964602635 cites W2003013566 @default.
• W1964602635 cites W2003470252 @default.
• W1964602635 cites W2020621227 @default.
• W1964602635 cites W2021693767 @default.
• W1964602635 cites W2021875656 @default.
• W1964602635 cites W2027544234 @default.
• W1964602635 cites W2029547213 @default.
• W1964602635 cites W2036110284 @default.
• W1964602635 cites W2037902239 @default.
• W1964602635 cites W2043131056 @default.
• W1964602635 cites W2065048549 @default.
• W1964602635 cites W2070386995 @default.
• W1964602635 cites W2073537725 @default.
• W1964602635 cites W2077850392 @default.
• W1964602635 cites W2080409198 @default.
• W1964602635 cites W2080752439 @default.
• W1964602635 cites W2081130105 @default.
• W1964602635 cites W2083132003 @default.
• W1964602635 cites W2088179332 @default.
• W1964602635 cites W2094418791 @default.
• W1964602635 cites W2103924560 @default.
• W1964602635 cites W2118246067 @default.
• W1964602635 cites W2123927174 @default.
• W1964602635 cites W2143378100 @default.
• W1964602635 cites W2146261786 @default.
• W1964602635 cites W2159127194 @default.
• W1964602635 cites W2159869226 @default.
• W1964602635 cites W2163394733 @default.
• W1964602635 cites W2176438348 @default.
• W1964602635 cites W2233541102 @default.
• W1964602635 cites W2244995601 @default.
• W1964602635 cites W2316274675 @default.
• W1964602635 cites W2316948580 @default.
• W1964602635 cites W2330418837 @default.
• W1964602635 cites W4313341466 @default.
• W1964602635 doi "https://doi.org/10.1177/153303460400300615" @default.
• W1964602635 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15560723" @default.
• W1964602635 hasPublicationYear "2004" @default.
• W1964602635 type Work @default.
• W1964602635 sameAs 1964602635 @default.
• W1964602635 citedByCount "55" @default.
• W1964602635 countsByYear W19646026352012 @default.
• W1964602635 countsByYear W19646026352013 @default.
• W1964602635 countsByYear W19646026352015 @default.
• W1964602635 countsByYear W19646026352016 @default.
• W1964602635 countsByYear W19646026352017 @default.
• W1964602635 countsByYear W19646026352018 @default.
• W1964602635 countsByYear W19646026352019 @default.
• W1964602635 countsByYear W19646026352020 @default.
• W1964602635 countsByYear W19646026352021 @default.
• W1964602635 countsByYear W19646026352022 @default.
• W1964602635 crossrefType "journal-article" @default.
• W1964602635 hasAuthorship W1964602635A5027152610 @default.
• W1964602635 hasAuthorship W1964602635A5031087657 @default.
• W1964602635 hasAuthorship W1964602635A5055713619 @default.
• W1964602635 hasAuthorship W1964602635A5066691984 @default.
• W1964602635 hasAuthorship W1964602635A5068736204 @default.
• W1964602635 hasAuthorship W1964602635A5078088995 @default.
• W1964602635 hasConcept C102230213 @default.
• W1964602635 hasConcept C104317684 @default.
• W1964602635 hasConcept C111599444 @default.
• W1964602635 hasConcept C121608353 @default.
• W1964602635 hasConcept C126322002 @default.
• W1964602635 hasConcept C135983454 @default.
• W1964602635 hasConcept C142724271 @default.
• W1964602635 hasConcept C150903083 @default.
• W1964602635 hasConcept C203014093 @default.
• W1964602635 hasConcept C207001950 @default.
• W1964602635 hasConcept C25938499 @default.
• W1964602635 hasConcept C2776256026 @default.
• W1964602635 hasConcept C2776914184 @default.
• W1964602635 hasConcept C502942594 @default.
• W1964602635 hasConcept C55493867 @default.
• W1964602635 hasConcept C71924100 @default.
• W1964602635 hasConcept C86803240 @default.

• next